Target intelligence / Profile preview

Ras-related protein Rap-1b (RAP1B)

Target
RAP1B
Molecular classification
Small GTPase, RAS superfamily, Signal transduction molecule, G protein
01

Overview

Ras-related protein Rap-1b (RAP1B) is a member of the small GTPase superfamily, specifically the RAS-like GTPase subfamily. RAP1B functions as a molecular switch cycling between inactive GDP-bound and active GTP-bound states, playing a central role in regulating integrin-mediated cell adhesion, cell polarity, and vascular integrity. It acts by binding effectors such as talin and orchestrating the localization and activation of integrins at the cell membrane, crucial for processes ranging from platelet aggregation (hemostasis) to endothelial cell junction formation. RAP1B is ubiquitously expressed but is particularly abundant in platelets, endothelial cells, and various tissues where precise regulation of cell-cell and cell-matrix interactions is essential. Dysregulation of RAP1B function is implicated in thrombocytopenia, developmental syndromes such as Kabuki syndrome, and various disorders of cell adhesion and proliferation

Other names
GTP-binding protein smg p21BOK/SW-cl.11K-REVRAL1BDKFZp586H0723THC11Ras family small GTP binding protein RAP1Bsmall GTP binding protein RAP1BRAS-related protein RAP1B
02

Mechanism of action

Not directly targeted by known clinical drugs; potential mechanisms include inhibition or modulation of GTPase activity, disruption of effector binding (e.g., to talin, integrin complexes), or interference with prenylation required for membrane localization

03

Biological functions

Signal transductionCell adhesionCell proliferationRegulation of integrin-mediated signalingEstablishment and maintenance of endothelial cell polarityCytoskeletal reorganizationRegulation of cell junctions
04

Disease associations

Thrombocytopenia (e.g., Thrombocytopenia 11 with multiple congenital anomalies)Kabuki syndrome 1CancerCardiovascular diseaseOther disorders involving cell adhesion or signaling
05

Safety considerations

Potential concerns would include interfering with fundamental cell adhesion and signaling; altered RAP1B activity could affect vascular integrity, platelet function, and normal development, raising risks for bleeding, vascular abnormalities, or developmental syndromes
06

Interacting drugs

None directly FDA-approved or widely reported as targeting RAP1B specifically as of this writing; research on direct pharmacological modulators for RAP1B is limited
07

Biomarkers

None routinely used in clinical practice for patient selection or monitoring; loss or abnormal activity of RAP1B may be useful in research biomarkers for platelet function or congenital thrombocytopenia syndromes

Beyond the preview

Go deeper on Ras-related protein Rap-1b (RAP1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rap-1b (RAP1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call